Gritstone Bio (GRTS) - Company Cash Volume

Official company branding of Gritstone bio Inc. (GRTS)

Geopolitical risks are disrupting supply chains, exacerbating the lack of revenue resulting from the judicial restructuring of Gritstone bio, Inc. (GRTS). The organization's cash balances reflect a burn rate, with the latest figure standing at 0.06. The future of Gritstone bio, Inc. (GRTS) relies on the EDGE AI platform to develop high-precision mRNA vaccines against solid tumors.

GRTS - gritstonebio.com Company Cash Reserve over the range 07/04/2022 - 11/02/2024

Analytical breakdowns for Gritstone bio, Inc.

- current price and projected stock value:
Fundamental company valuation:Gritstone bio GRTS
Brand item of Gritstone bio, Inc.

This metric reflects the volume of free liquidity in the accounts of Gritstone bio, Inc., measuring the company's ability to cover operating expenses without incurring debt. While growing reserves enhance stability, an excess of non-working capital may reduce overall return on assets. By analyzing the cash position chart, an investor assesses the risk of a funding shortfall. For GRTS, this metric is critical during the period of clinical program reductions. The current cash balance determines the ability to complete colon cancer vaccine trials amidst ongoing litigation.

Competitors of Gritstone bio, Inc. (GRTS)

Company Cash on Hand IBRX (ImmunityBio Corp)|Company Total Cash Amount IMCR|Company Cash Volume JANX (Janux Therapeutics, Inc.)|Company Cash Balance RCUS|zymeworks.com - Company Cash Volume|Company Cash Reserve Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Company Cash Funds|Immatics N.V. - Company Cash Balance|XNCR (xencor.com) - Company Cash Volume|Company Cash Volume Compass Therapeutics Inc|Company Cash Funds Replimune (REPL)|LYEL: Company Total Cash Volume|Innate Pharma SA - Company Cash on Hand|Pyxis Oncology, Inc. (PYXS) - Company Cash Reserve|Compugen - Company Cash Volume|Company Liquid Assets IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Company Cash on Hand|INKT - Company Liquid Assets|Company Cash Funds werewolftx.com|Company Cash on Hand Immix Biopharma, Inc. (IMMX)|Company Cash on Hand ALXO (ALX Oncology Holdings)|Company Cash Funds CUE (Cue Biopharma)|Company Cash Volume PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Company Cash Reserve|MAIA Biotechnology - Company Cash Volume|LIMN - Company Cash Volume|LVTX: Company Cash Volume|NextCure - Company Cash Balance|LPTX (Leap Therapeutics Inc) - Company Cash Volume|INTS (Intensity Therapeutics, Inc.) - Company Total Cash Amount|Company Cash Volume SNSE|Company Cash Funds TOVX (Theriva Biologics, Inc.)|Company Cash Funds kinetabio.com KA|Company Cash Balance NEXI|turnstonebio.com - Company Cash Volume|VCNX (Vaccinex, Inc) - Company Cash and Cash Equivalents|Harpoon Therapeutics (HARP) - Company Cash Funds